Join
Live feed
·
NEWSReleasevia Quantisnow
Evotec SE logo

Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses

ByQuantisnow·Wall Street's wire, on your screen.
EVO· Evotec SE
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVO (Evotec SE) and more on Quantisnow.